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INTRODUCTION
Knowledge regarding endosseous dental implants 
has rapidly expanded over the last years, making them 
a viable treatment alternative to replace missing teeth 
in many different situations with predictable high clini-
cal success rates (1). Great part of this approach can 
be explained by the development of implant surfaces 
that improved implant anchorage with enhanced bone 
apposition (2,3).
As a critical factor for osseointegration, the na-
ture of the implant surface remains under investigation. 
Among the different surface properties that influence 
bone apposition around titanium implants, the topog-
raphy has been extensively explored. It was recognized 
that microstructured surfaces provide higher success 
rates when compared to smooth or machined surfaces. 
Increased cell migration and proliferation (4) as well 
as enhanced bone apposition (5) and bone-to-implant 
contact (6) are some findings of in vitro and in vivo stud-
ies that support the superiority of the microstructured 
surfaces. Additionally, it has been shown that implants 
with this kind of rough surface require a greater torque 
for removal when compared to smooth surfaces (7), and 
also that implant roughness is important when immediate 
loading is to be applied (8).
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Among the different properties that influence bone apposition around implants, the chemical or biochemical composition of implant 
surface may interfere on its acceptance by the surrounding bone. The aim of this study was to investigate if a biofunctionalization of 
implant surface influences the bone apposition in a dog model and to compare it with other surfaces, such as a microstructured created 
by the grit-blasting/acid-etching process. Eight young adult male mongrel dogs had the bilateral mandibular premolars extracted and 
each one received 6 implants after 12 weeks, totaling 48 implants in the experiment. Four groups of implants were formed with the 
same microrough topography with or without some kind of biofunctionalization treatment. After histomorphometric analysis, it was 
observed that the modified microstructured surface with a “low concentration of the bioactive peptide” provided a higher adjacent 
bone density (54.6%) when compared to the other groups (microstructured + HA coating = 46.0%, microstructured only = 45.3% 
and microstructured + “high concentration of the bioactive peptide” = 40.7%), but this difference was not statistically significant. In 
conclusion, biofunctionalization of the implant surface might interfere in the bone apposition around implants, especially in terms of 
bone density. Different concentrations of bioactive peptide lead to different results.
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Bone is a complex composite in which a very 
large mineral component occurs in close association 
with collagen. Collagen comprises >90% of the spa-
tially fixed matrix of bone and is the major regulator 
of cell adhesion (9) and osteogenic differentiation (10), 
serving as conduit for a variety of biochemical and 
biomechanical signals between cells. Recently, some 
studies have focused on the mechanisms of interaction 
between proteins from the extra-cellular matrix (ECM) 
and cell membrane receptors (11,12). Several of these 
biomolecules (native proteins and synthetic peptides) 
are known to control cell adhesion and growth. The 
most investigated mechanism for osteoblast adhesion 
implies the interaction with arginine-glycine-aspartic 
acid (RGD) peptide sequences via cell-membrane inte-
grin receptors (13). Thus, the RGD sequence has been 
extensively used as a candidate peptide to enhance cell 
adhesion onto biomaterial surfaces (14).
Generally, the bone-to-implant interaction is 
complex and does not depend on surface topography 
only. Chemical or biochemical composition of implant 
surface also plays a key role in the early stages of bone 
formation (15,16). Cell recruitment onto biomaterial 
surface is a fundamental step within the multifaceted 
process responsible for implant osseointegration. This 
process involves several proteins from the (ECM), 
cytoskeleton and cell membrane (17). Thus, it could 
be suggested that the biofunctionalization of implant 
surfaces, by associating on them adhesive factors to 
cells, may interfere in the acceptance and bonding of 
the implant to the surrounding bone. Biofunctionalized 
surfaces that mimic the bone tissue environment may be 
expected to enhance the performance of dental implants, 
encouraging the initial biologic response (17).
The purpose of this histomorphometric study was 
to investigate whether biofunctionalized implant surface 
containing a low or high concentration of a bioactive 
peptide influences the bone-implant contact and density 
around implants compared to standard grit-blasted and 
acid-etched implant surface.
MATERIAL AND METHODS
Implant Design and Fabrication
All implants were fabricated from commercially 
pure titanium following the XiVE design (Dentsply 
Friadent, Mannheim, Germany) and measured 4.5 mm x 
9.5 mm. The implants were characterized by an indenta-
tion placed 2.3 mm from the top of the implant with a 
depth of 0.18 mm and a height of 1.5 mm (Fig. 1). In 
this indentation, 4 different coatings were performed 
constituting the 4 different implant groups: A, B, C and 
D. Firstly, the indentations of all 4 groups were lined 
by the microstructured Friadent plus surface (Dentsply 
Friadent) provided by the sandblasting/acid-etching 
process. For biofunctionalization of the implant surface, 
a bioactive peptide was absorbed to nano-crystalline 
HA coatings and diluted in PBS solution. The bioactive 
peptide could also be described as a sequence of ami-
noacids related to bone formation; however the detailed 
composition has not been disclosed by the manufacturer 
(proprietary processing). Thus, group A was constituted 
by the Friadent plus surface morphology coated with 
nano-crystalline HA coating and a “low concentration” 
(20 mg/mL) of the bioactive peptide, while group D 
had the same characteristics but a “high concentration” 
(200 mg/mL) of the bioactive peptide. In group B, the 
implants were lined by the Friadent plus surface in 
conjunction with the nano-crystalline HA coating alone 
and group C was prepared only with the Friadent plus 
surface. It is important to emphasize that the Friadent 
plus surface morphology was not changed due to the 
surfaces’ biofunctionalization process. The Friadent plus 
Figure 1. Implant design. All implants had the same shape and 
topography (grit-blasted/acid-etched surface), but received 4 
different surface coatings performed in the indentation placed 
2.3 mm from the top of the implant with 0.18 mm depth and 1.5 
mm height (arrow).
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surface morphology was fully maintained following the 
application of a thin HA + bioactive peptide coating as 
seen in the scanning electron microcopy images (Fig. 2). 
The study was blinded, that is, all involved profes-
sionals (from the surgeon to the examiner of the histo-
logic specimens) had no knowledge of the constitution 
of the groups. The different coatings that characterized 
the 4 different implant surfaces were only revealed when 
the histomorphometric analysis was completed. 
Surgical Procedure
The study protocol was approved by the insti-
tutional Animal Research Committee and involved 2 
surgical interventions that were performed in 8 young 
adult male mongrel dogs, weighing approximately 12 
kg. The animals presented intact maxillas, no general 
occlusal trauma, no oral viral or fungal lesions, and 
were in good general health, with no systemic involve-
ment as determined by a veterinarian following clinical 
examination.
In the first surgery, the dogs were sedated and 
anesthetized with an endovenous injection of thiopental 
(1 mL/kg; 20 mg/kg thiopental diluted in 50 mL saline). 
Subsequently, full-thickness flaps were bilaterally el-
evated in the area of the 1st to 4th mandibular premolars. 
The teeth were sectioned in a buccolingual direction at 
the bifurcation so that the roots could be individually 
Figure 2. Panel of SEM micrographs. (A) View of the microstructured surface provided by sandblasting/acid-etching (×1,000 
magnification); (B) The same microstructured surface at higher magnification (×10,000 magnification); (C) The microstructured surface 
after coating with HA (×1,000 magnification), note the uniform coating not changing the original morphology; (D) The microstructured 
surface after coating with HA and adsorption of the bioactive peptide (×10,000 magnification).
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extracted, without damaging the bone walls, using a 
periotome. The flaps were repositioned and sutured with 
non-absorbable 4-0 sutures. 
After a healing period of 3 months, the animals 
received 20,000 IU penicillin and streptomycin (1.0 g/10 
kg body weight) the night before the second surgery. 
This dose provides antibiotic coverage for 4 days, thus 
another dose was given 4 days later to provide coverage 
for a total of 8 days. After repeating the same sedation 
and anesthesia used in the first surgeries, horizontal 
crestal incisions were bilaterally performed from the 
distal region of the canine to the mesial region of the first 
molar. Three implants were randomly inserted in each 
side of the mandible of each animal. Thus, the locations 
and sides of the mandibles of the animals were treated 
with different sequences of implant groups. A total of 48 
implants were disposed in the experiment, 12 for each 
group (A, B, C or D). The flaps were sutured with non-
absorbable sutures and the implants were left to heal in 
a submerged position. The animals were maintained on 
a soft diet for 14 days when the sutures were removed. 
The healing was evaluated periodically and the remain-
ing teeth were cleaned monthly with ultrasonic tips. 
Sacrifice and Histological Processing 
The animals were sedated and sacrificed by 
anesthetic overdose 8 weeks after implant placement. 
The hemi-mandibles were removed, dissected and 
fixed in 4% phosphate-buffered formalin pH 7, for 10 
days, and transferred to a solution of 70% ethanol until 
processing. The specimens were dehydrated in a series 
of increasing ethanol concentrations up to 100%, infil-
trated and embedded in LR White resin (London Resin 
Company, Berkshire, England), and then hard-sectioned 
(18). The sections were prepared for histomorphometry 
and stained with Stevenel’s blue and Alizarin red S for 
optical microscopy.
Histomorphometric Analysis
Longitudinal histological sections from each 
implant were captured through a video camera Leica 
DC 300F (Leica Microsystems GmbH, Nussloch, 
Germany) joined to a stereomicroscope Leica MZFL 
III (Leica Microsystems GmbH, Nussloch, Germany). 
The images were analyzed using the Image J program 
(National Institutes of Health, Bethesda, MD, USA), to 
determine the percentages of bone-to-implant contact 
(BIC) and bone density within the indentations.
The percentages of mineralized bone in direct 
contact with the implant surface (BIC) were determined 
within the indentations by linear measurements (19). 
The bone density was determined within two rectangles, 
one of them inside the indentation (BDA), occupying its 
total area, and the other outside the indentation (BDD) 
as mirror image of the first. The bone density measure-
ments evaluated the percentages of mineralized bone in 
relation to the percentages of marrow cavities. A single 
examiner blinded to the made all measurements.
Statistical Analysis
The values of bone-implant contact and bone 
density were statistically analyzed using a mixed linear 
model for multiple variables and a standard 2-sample t-
test for a single variable. In the mixed linear model with 
the SAS/STAT software (SAS Inst. Inc., Cary, NC, USA) 
a compound-symmetry covariance structure between the 
data was assumed to perform 2 repeated- measurements 
(side, surface). Repeated measurements within the same 
animal were done using a Tukey-adjusted multiple mean 
value comparison. The independent 2 sample t-test was 
applied between all mean values within different surface 
modifications using the SPSS software (SPSS GmbH 
Software, München, Germany).
RESULTS
After implant placement, healing progressed 
uneventfully during the 8-week postoperative period 
without significant signs of inflammation. The radio-
graphic evaluation of the implants immediately before 
the sacrifice revealed normal bone conditions, thus the 
total sample of 48 implants (12 of each group) were 
analyzed histomorphometrically.
Histologic Observations
The bone-implant interface had mineralized bone 
matrix in intimate contact with the implant surface in 
the 4 groups. 
The bone tissue was characterized by the presence 
of concentric or parallel lamellar formations. Central 
canals of different diameters lined by endosteum were 
observed and were in close contact with the implant 
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surface at some points (Fig. 3).
Histomorphometric Findings
The implant surface characterization of each ex-
perimental group A, B, C or D was previously described. 
The histomorphometric results of the percentages of 
direct BIC within the implant indentations (Table 1) 
revealed that the highest mean value of 65.4 ± 17.1% 
for group D (ranging from 20.8 to 88.5%). In sequence, 
group B had a BIC mean of 62.4 ± 17.4% (ranging from 
28.9 to 96.2%), group A 60.4 ± 17.5% (ranging from 
28.1 to 90.5%) and, finally, group C that showed a nu-
merically inferior BIC mean of 58.0 ± 11.8% (ranging 
from 38.7 to 72.5%) when compared to the other groups. 
No statistically significant differences (p>0.05) were 
detected between the groups.
Bone density analysis revealed that the percentage 
Figure 3. Histological images (Stevenel’s blue and Alizarin red S staining) obtained in a close-up view of the indentation area of each 
experimental surface. (A) Group A implant (microstructured surface modified with a “low concentration” of the bioactive peptide). 
Observe a strict contact between bone and implant and a high histological bone density with just a few marrow spaces adjacent to the 
implant surface; (B) Group B implant (microstructured surface in conjunction with the nano-crystalline HA coating). Observe a high 
percentage of bone-to- implant contact and central canals of different diameters; (C) Group C implant (microstructured surface only). 
Observe a superior number of marrow spaces, which presents bigger diameters when compared to the other histological images; (D) 
Group D implant (microstructured surface modified with a “high concentration” of the bioactive peptide). Note good levels of bone-
to-implant contact and histological bone density.
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of bone in adjacent areas for group A was 54.6 ± 16.6% 
(ranging from 30.8 to 78.9%); for group B it was 46.0 ± 
21.0% (ranging from 16.1 to 87.7%); for group C 45.3 ± 
11.3% (ranging from 28.4 to 62.4%) and for group D 40.7 
± 15.3% (ranging from 17.4 to 64.0%) (Table 1). However, 
the differences between the groups were not statistically 
significant (p>0.05). The average of bone densities in areas 
distant from the implants was 47.0 ± 16.8 % (ranging from 
15.2 to 68.9%) for group A, 44.9 ± 17.5% (ranging from 
16.5 to 87.0%) for group B, 44.6 ± 14.6% (ranging from 
21.8 to 75.6%) for group C and 41.4 ± 18.7% (ranging 
from 12.7 to 68.4%) for group D (Table 1) and again the 
results were not statistically significant (p>0.05).
DISCUSSION
A new strategy to improve endosseous implant 
integration is based on preparing biofunctionalized sur-
faces with  inclusion of cell adhesive factors, for example.
Cell adhesion is a fundamental process directly 
involved in cell growth, cell migration, and cell differ-
entiation. It is concerned in embryogenesis, maintenance 
of tissue integrity, wound healing, immune response, 
and biomaterial tissue integration. Several proteins 
are involved in cell adhesion, such as extracellular 
matrix proteins (collagen, fibronectin, vitronectin) and 
membrane receptors (integrins). Interactions between 
these proteins and their specific receptors induce signal 
transduction and consequently influence cell growth and 
differentiation (11).
The development of bone-implant interfaces 
depends on the direct interactions of bone matrix and 
osteoblasts with the biomaterial. Osteoblast adhesion is 
therefore essential for bone-biomaterial interactions (11).
It has been shown in vitro that a functionalized 
titanium substrate with synthetic peptides may enhance 
the adhesion of human osteoblast-like cells (17). The 
presence of synthetic peptides also demonstrates an 
increase in the osteogenic gene expression for alkaline 
phosphatase and for BMP-2 and BMP-7. These BMPs 
have been reported to stimulate 
osteoblastic activity through 
autocrine and paracrine mecha-
nisms (20). 
In the present study, 
a biofunctionalized implant 
surface with different concen-
trations of a bioactive peptide 
was tested in an animal model, 
providing histomorphometric 
analysis of the bone density 
and bone-implant contact. The 
modified Friadent plus-surface 
with a low concentration of the 
bioactive peptide (group A im-
plants) provided a higher adja-
cent bone density (54.6%) when 
compared with the other group 
surfaces (group B = 46.0%, 
group C = 45.3% and group D 
= 40.7%). The difference was 
only numeric, without  statisti-
cal significance, which may be 
partially due to the sample size. 
The average of bone density in 
areas distant from the implants 
was also higher in the group A, 
but not as evident as the other 
Table1. Effect of implant surface on bone-to-implant contact (BIC), bone density/adjacent 
(BDA) and bone density/distant (BDD).
Group n Variable Mean* SD* Minimum value
Maximum 
value
A 12
BIC 60.41 17.56 28.10 90.50
BDA 54.67 16.63 30.80 78.90
BDD 47.07 16.84 15.20 68.90
B 12
BIC 62.43 17.44 28.90 96.20
BDA 46.02 21.04 16.10 87.70
BDD 44.99 17.53 16.50 87.00
C 12
BIC 58.00 11.85 38.70 72.50
BDA 45.30 11.35 28.40 62.40
BDD 44.66 14.64 21.80 75.60
D 12
BIC 65.41 17.17 20.80 88.50
BDA 40.71 15.37 17.40 64.00
BDD 41.42 18.78 12.70 68.40
n = number of implants in each group. *Percent values expressed as means and standard 
deviation (SD).
Braz Dent J 20(2) 2009
Biofunctionalized implant surface 97
parameter. According to the histograms (Fig. 4) that 
show the dispersion of the bone density values for all 
implant surface groups, the group A achieved a better 
performance when compared with the other groups. 
In this group, 7 out of 12 implants showed 40-60% of 
BDA, 3 implants achieved more than 70% of BDA and 
no implants had less than 30% of BDA. The presence 
of a high concentration of the bioactive peptide did not 
provide any advantages considering the group A bone 
density results. Although 6 out of 12 implants showed 
40-60% of BDA in the group D, no implants achieved 
more than 70% of BDA and 3 implants had less than 
30% of BDA. Thus it could be concluded that the con-
centration of the bioactive peptide interferes in the bone 
apposition process and that the low concentration was 
better than the high concentration. The histogram analy-
sis also shows that the group C exhibited inferior results 
when compared with group A. In this group C, which 
represents the grit-blasted/acid-etched implant surface 
(Friadent plus surface), 6 out of 12 implants the showed 
40-60% of BDA, but no implants achieved more than 
70% of BDA and 2 implants had less than 30% of BDA. 
Finally, in group B (Friadent plus surface in conjunction 
with the nano-crystalline HA coating alone), 5 out of 12 
implants showed 40-60% of BDA, 2 implants achieved 
more than 70% of BDA and 3 implants had less than 30% 
of BDA. These results indicate that biofunctionalization 
could positively interfere in the bone apposition process. 
Germanier et al. (15) recently observed in an in vivo study 
that the topography is not the only surface character-
istic capable of enhancing new bone apposition. 
Besides, Schuler et al. (16) showed in an in vitro 
study that surface chemistry also influenced the 
attachment and morphology of cells. In general, 
an increase in cell number and more spread cells 
were observed on bioactive substrate (containing 
RGD) compared to bio-inactive surfaces accord-
ing to their findings. In the present study, it is not 
possible to describe exactly how the low bioactive 
peptide concentration coating acts during bone 
healing; one hypothesis is that the improvement 
of the surface biochemical composition was able 
to enhance its ability to interact with cells by 
mechanisms that simulate the interaction of cells 
with their extracellular matrices. 
Interestingly, the low concentration modi-
fied Friadent plus surface did not show higher BIC 
mean values when compared to the other surfaces. 
Instead, statistically similar mean values were 
observed for the 4 groups (A=60.4%, B=62.4%, 
C=58.0% and D=65.4%). According to the results, 
it may be concluded that the establishment of the 
bone-to-implant contact was influenced mainly by 
the underlying pore structure of the Friadent plus 
surface, which was not altered by the biofunction-
alization. However, further research is required. 
Biofunctionalization of implant surfaces is 
still a poorly investigated area. The enhancement 
of bone density around the modified-Friadent plus 
surface (low concentration of bioactive peptide) is 
promising. Further in vitro and in vivo studies are 
necessary to elucidate how and in which extent 
biofunctionalization of the implant surfaces could 
Figure 4. Histograms showing the dispersion of bone density (BD) 
values for all implant surface groups. (A) In group A 7 implants from 
12 showed 40-60% of BD, 3 implants achieved more than 70% and no 
implants had less than 30%; (B) In group B 5 implants from 12 showed 
40-60% of BD, 2 implants achieved more than 70% and 3 implants had 
less than 30%, (C) In group C 6 implants from 12 showed 40-60% of 
BD, no implants achieved more than 70% and 2 implants had less than 
30%; (D) In group D 6 implants from 12 showed 40-60% of BD, no 
implants achieved more than 70% and 3 implants had less than 30%.
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represent an advantageous modification.
In conclusion, biofunctionalization of implant 
surface interferes in bone apposition around titanium 
implants, especially in the bone density, and different 
bioactive peptide concentrations lead to different results.
RESUMO
Entre as diferentes propriedades de uma superfície capazes de 
influenciar a deposição óssea ao redor de implantes, a composição 
química e bioquímica pode atuar no reconhecimento do tecido 
ósseo circundante. O presente trabalho investigou a influência 
da biofuncionalização de superfícies de implante na deposição 
óssea ao redor dos mesmos em um modelo animal, comparando-
as com outras superfícies, como a microtexturizada obtida pelo 
processo de jateamento e ataque ácido. Metodologicamente, os 
pré-molares mandibulares bilaterais de 8 cães foram extraídos 
e após 12 semanas foram instalados 6 implantes em cada cão, 
constituindo uma amostra de 48 implantes. Dos 4 grupos ex-
perimentais de diferentes superfícies, todos continham a mesma 
microtopografia rugosa, porém possuindo ou não alguma biofun-
cionalização. A análise histomorfométrica revelou que a superfície 
microtexturizada modificada pela adição de baixa concentração 
peptídica obteve uma maior densidade óssea adjacente (54,6%) 
quando comparada aos outros grupos (microtexturizada + HA = 
46%, somente microtexturizada = 45,3% e microtexturizada com 
adição de alta concentração peptídica = 40,7%), no entanto estas 
diferenças numéricas não foram estatisticamente significantes. 
Dentro deste contexto, conclui-se que a biofuncionalização da 
superfície de implantes pode interferir na aposição óssea, em 
particular na densidade óssea, e que diferentes concentrações 
peptídicas podem conduzir a diferentes resultados.
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